FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition containing an IL-15 protein complex and a buffer based on citric acid and sodium citrate, trehalose and polysorbate 20.
EFFECT: pharmaceutical composition of the present disclosure demonstrates a high degree of stability even after being stored at a temperature between 2 and 8°C for several months.
26 cl, 3 dwg, 8 tbl, 7 ex
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO SOST, AND ITS USE |
2018 |
- Fang Jingjing
- Yan Zhen
- Liu Xun
|
RU2779430C2 |
| PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION |
2019 |
- Tyan, Chenmin
- Li, Khao
- Lyu, Syun
|
RU2791683C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-5 ANTIBODY, AND USE THEREOF |
2020 |
- U, Tintin
- Li, Khao
- Lyu, Syun
- Tao, Vejkan
|
RU2824390C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE |
2018 |
- Tian, Chenmin
- Li, Hao
- Liu, Xun
|
RU2782792C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODIES AGAINST CD40 AND APPLICATION THEREOF |
2019 |
- Yang, Jianjian
- Li, Hao
- Liu, Xun
- Jiang, Jiahua
|
RU2778572C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO LAG-3 AND ITS USE |
2018 |
- Wu Tingting
- Li Hao
- Liu Xun
- Fu Yayuan
|
RU2771384C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODY TO PD-L1 AND ITS APPLICATION |
2018 |
- Yan, Zhen
- Yang, Jianjian
- Yan, Xiaodan
- Wu, Shan
- Liu, Xun
|
RU2766590C2 |
| FUSED PROTEIN CONTAINING TGF-BETA RECEPTOR, AND ITS PHARMACEUTICAL USE |
2018 |
- Gu, Tszinmin
- Lo, Syao
- Tao, Vejkan
|
RU2776204C1 |
| HUMAN INTERLEUKIN-2 VARIANT OR ITS DERIVATIVE |
2019 |
- Chen, Lej
- Khu, Tsiyue
- Ge, Khu
- Lin, Yuan
- Van, Khunvej
- Ou, Yanchao
- Kun, Syanlin
- Lyao, Chen
- Chzhan, Lyanshan
|
RU2799437C2 |
| ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE |
2018 |
- In, Khua
- Shi, Tszinpin
- Van, Ifan
- Khu, Tsiyue
- Ge, Khu
- Tao, Vejkan
|
RU2772716C2 |
